Home/Filings/4/0001209191-22-005978
4//SEC Filing

Dhaliwal Harpreet S. 4

Accession 0001209191-22-005978

CIK 0001649094other

Filed

Jan 31, 7:00 PM ET

Accepted

Feb 1, 5:41 PM ET

Size

5.6 KB

Accession

0001209191-22-005978

Insider Transaction Report

Form 4
Period: 2021-11-08
Dhaliwal Harpreet S.
Chief Technical Ops Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-11-08+100,000100,000 total
    Exercise: $25.06Exp: 2031-11-07Common Stock (100,000 underlying)
Footnotes (1)
  • [F1]1/4 of the shares subject to the option shall vest on October 1, 2022, and 1/48 of the shares shall vest monthly thereafter, subject to Reporting Person's continuous service to the Company through each such date

Issuer

Vaxcyte, Inc.

CIK 0001649094

Entity typeother

Related Parties

1
  • filerCIK 0001886794

Filing Metadata

Form type
4
Filed
Jan 31, 7:00 PM ET
Accepted
Feb 1, 5:41 PM ET
Size
5.6 KB